گروه دارویی برکت
برکت | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 5,070 1.81
Close Price: 5,050
Financial Ratios
AGM
Interim
2026/07/02 Fiscal Year 2026/03/2012 Month | 2025/06/02 Fiscal Year 2025/03/2012 Month | 2024/07/03 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 49.24 | 21.27 | 230 | |
Gross Profit to Sales | 49.24 | 21.27 | 230 | |
Operating Margin | 69.84 | 38.4 | 82.7 | |
Gross Profit to Sales | 100 | 100 | 100 | |
Net Profit to Gross Profit | 49.24 | 21.27 | 230 | |
Return on Assets (ROA) | 1.88 | 0.39 | 13.08 | |
Return on Capital (%) | 7.61 | 1.32 | 38.86 | |
Return on Equity (ROE) | 4.17 | 0.75 | 20.64 | |
Working Capital Return | -5.61 | -4.78 | 343.35 | |
Fixed Asset Return | 234.55 | 430.42 | 8,281.74 | |
Loan Benefit Assessment | 2.22 | 1.92 | 1.58 | |
Current Ratio | 0.39 | 0.8 | 1.13 | |
Quick Ratio | 0.39 | 0.8 | 1.13 | |
Liquidity Ratio | 0.07 | 0.01 | 0.02 | |
Net Working Capital | -23,506,622 | -4,782,266 | 1,962,555 | |
Current Assets Ratio | 0.21 | 0.33 | 0.33 | |
Receivables Collection Period | 1,656.74 | 6,452.97 | 2,062.84 | |
Inventory to Working Capital | - | 0 | - | |
Working Capital Turnover | -0.11 | -0.22 | 1.49 | |
Fixed Asset Turnover | 4.76 | 20.24 | 36.01 | |
Total Asset Turnover | 0.04 | 0.02 | 0.06 | |
Debt Ratio | 0.55 | 0.48 | 0.37 | |
Debt to Equity | 1.22 | 0.92 | 0.58 | |
Long-Term Debt to Equity | 0.01 | 0.13 | 0.12 | |
Current Debt to Equity | 1.21 | 0.79 | 0.46 | |
Equity Ratio | 45.01 | 51.96 | 63.35 | |
Debt Coverage Ratio | 1.9 | 0.01 | 0.02 |